Release Date: 10/12/09 09:42 Summary: MUE - Board and Management Changes Price Sensitive: No Download Document 140.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%